Meet the core team

The HRB-TMRN core team operate from the School of Nursing and Midwifery NUI Galway. Our Core Team is responsible for ensuring the operation, implementation and running of all network services nationally. You can contact the core team via email at hrb-tmrn@nuigalway.ie or by phone 091 494492.

  • Prof. Declan Devane

    Declan is Director of the Health Research Board – Trials Methodology Research Network (HRB-TMRN), Professor of Midwifery at NUI Galway and Principal Investigator with the SFI – INFANT – Irish Centre for Fetal and Neonatal Translational Research. He is an Editor with the Cochrane Pregnancy and Childbirth Group and an Honorary Senior Lecturer at Cochrane UK. Declan’s methodological areas of expertise are randomised trials, systematic reviews and meta-analyses. He has published over 130 papers including numerous Cochrane systematic reviews predominantly in the field of fetal assessment. He has led a number of clinical trials recruiting from 100 to over 3000 participants and serves on a number of Trial Steering Committees including those in pregnancy (e.g., EMERGE, HOLDS, PARROT) and Data Monitoring Boards (e.g., CORD, KEEP-WELL).Declan has a particular interest in the implementation and evaluation of models of maternity care and on methods of fetal monitoring including cardiotocography and intermittent auscultation. Declan has been awarded over €5 million in research funding as PI or co-PI and a further €8 million as co-applicant. He holds or has held awards from the Health Research Board (Ireland), Department of Health and Children (Ireland), National Council for the Professional Development of Nursing and Midwifery (Ireland), Royal College of Midwives (UK), the Health Services Executive (Ireland) and the EU.

    • Dr. Sandra Galvin

      As Programme Manager for the Health Research Board –Trial Methodology Research Network (HRB-TMRN) Dr Galvin is responsible for the development, maintenance and expansion of an energetic, adaptive, and innovative network. Along with the Executive Committee, Sandra is responsible for shaping the strategic direction of the network as well as delivering on the core activities of the network. Sandra is responsible for the networks initiation and expansion, strategic development, coordination of events and maintenance of Ireland’s first Clinical Trial Expertise Database (C-TED) and for running the Trial Methodology and Reporting Advisory Service (TMRAS), as well as promoting the network via social media and attendance at conferences and events. Sandra has led on creating a number of key collaborations with national organisations to improve and build on the current randomised trial support infrastructure in Ireland.

      • Carol Burke
        Carol Burke

        Carol Burke joined the Health Research Board -Trial Methodology Research Network (HRB-TMRN) in September 2017 as the Senior Administrator. Her role includes supporting the Director and Programme Manager within the network. Carol brings years of administrative and financial management experience to the team, having previously worked in numerous positions within NUI, Galway and also in industry.

        Executive Management Committee

        The HRB-TMRN Executive Management Committee is responsible for developing the strategic direction and is the governing body for the network. This committee comprises of members from across all five funded university partners (NUI Galway, UCC, UCD, TCD and UL), with each member bringing a wealth of relevant experience to the network.

        • Prof. Declan Devane

          Declan is Director of the Health Research Board – Trials Methodology Research Network (HRB-TMRN), Professor of Midwifery at NUI Galway and Principal Investigator with the SFI – INFANT – Irish Centre for Fetal and Neonatal Translational Research. He is an Editor with the Cochrane Pregnancy and Childbirth Group and an Honorary Senior Lecturer at Cochrane UK. Declan’s methodological areas of expertise are randomised trials, systematic reviews and meta-analyses. He has published over 130 papers including numerous Cochrane systematic reviews predominantly in the field of fetal assessment. He has led a number of clinical trials recruiting from 100 to over 3000 participants and serves on a number of Trial Steering Committees including those in pregnancy (e.g., EMERGE, HOLDS, PARROT) and Data Monitoring Boards (e.g., CORD, KEEP-WELL).Declan has a particular interest in the implementation and evaluation of models of maternity care and on methods of fetal monitoring including cardiotocography and intermittent auscultation. Declan has been awarded over €5 million in research funding as PI or co-PI and a further €8 million as co-applicant. He holds or has held awards from the Health Research Board (Ireland), Department of Health and Children (Ireland), National Council for the Professional Development of Nursing and Midwifery (Ireland), Royal College of Midwives (UK), the Health Services Executive (Ireland) and the EU.

          • Prof. Alistair Nichol
            Prof. Alistair Nichol

            Alistair is the Chair and Professor of Critical Care Medicine in University College Dublin (UCD), the Chair of the Irish Critical Care-Clinical Trails Group (ICC-CTG), Director of the HRB Irish Critical Care- Clinical Trials Network (HRB ICC-CTN), Dept Director of the Australian and New Zealand Intensive Care-Research Centre (ANZIC- RC), Monash University, Melbourne and an Honorary Research Fellow, School of Tropical Medicine, University of Oxford.
            Alistair is a senior clinical intensivist, laboratory scientist and clinical trialist. Alistair and his collaborators have successfully completed a number of important trials and epidemiological studies (enrolled over 10,000 patients in the last 10 years), including during the H1N1 2009 pandemic (900 patients) published in the NEJM, an RCT of Erythropoietin in traumatic brain injury (606 patients) published in the Lancet (first author-joint). Furthermore he is a Work Package leader of a European Union FP-7 project, which is charged with examining the challenges of conducting interventional studies in critically ill patients throughout Europe.This project is examining embedding of research into clinical practise, examining the acceptability and understanding of consent process used in the critically ill. To date Professor Nichol’s collaborations have been awarded over €35,000,000 in research funding. This has included an award for TRANSFUSE (HRB Definative Intervention award) published in the NEJM this year (5000 patients, first author-joint) and a Clinical Trial Network Award (Improving outcomes in the critically ill) from the Health Research Board of Ireland.

            • Dr Frances Shiely
              Dr Frances Shiely

              Dr Frances Shiely qualified with a BA from the University of Limerick in 1998 and a PhD degree in Epidemiology in 2003. She was recently awarded a Masters in Teaching and Learning in Higher Education from UCC (2017). She was appointed as Lecturer in Epidemiology and Public Heath in UCC in 2005 and is currently a Senior Lecturer, jointly appointed to the School of Public Health and the HRB Clinical Research Facility. Frances is a member of the BSc Public Health Sciences Executive Committee which leads on curricular development and the implementation of the degree programme. She is also one of the core teaching faculty for the degree on which she has taught since her appointment in 2005. She has also taught on the MPH, Dental MPH, MA Gerontology and the undergraduate medical programme. Frances was appointed as Education lead for the HRB CRF-C in 2015 and is co-PI and UCC lead on the HRB Trials Methodology Research Network Grant. She currently supervises 5 PhD students and has extensive experience supervising MPH and undergraduate projects. Frances has two main research interests: clinical trial methodology and physical activity and diet related research for the prevention of disease.

              • Prof. Mary Codd
                Prof. Mary Codd

                Mary Codd graduated in medicine from University College Dublin. Following residency in internal medicine at the Mater Misericordiae Hospital, Dublin, and Middlesex Hospital, London, she trained in Epidemiology and Biostatistics at the Mayo Clinic, Rochester, MN, and School of Public Health, University of Minnesota. Mary was appointed to UCD in 2008 and is Associate Professor of Epidemiology & Biostatistics at the School of Public Health, Physiotherapy & Sports Science. She teaches epidemiology, applied research methods and data management, biostatistics and computational methods at all levels from undergraduate through to post-doctoral students. She is Director of the UCD MPH programme, delivered at both UCD and Penang Medical College, Malaysia. She is also Director of the consultative group, UCD CSTAR, a recognised UCD Academic Centre for Support and Training in Analysis & Research.

                • Dr Peter Doran
                  Dr Peter Doran

                  Prof. Peter Doran earned his BSc. from Dublin City University in 1998 and his PhD from University College Dublin in 2001. He is associate professor at the UCD School of Medicine, Director of the Ireland East Hospital Group research network and Scientific Director of the UCD Clinical Research Centre (CRC). The clinical research, directed by Prof Doran, helps discover ways to improve medical care and to establish new treatments which in turn will improve the quality of life for patients who are living daily with chronic illness. The CRC contributes to ongoing research creating a scientific and caring culture for the benefit of present and future patients and medical research contributes to the development of new cures and better treatments. Prof Doran also leads the UCD-Abbott Biomarker programme, which has established a high throughput biomarker validation laboratory, which is contributing to major national and international end organ damage biomarker studies, reflecting his research interests in the molecular drivers of organ damage, biomarker discovery and translation to practice. In addition to his research and leadership roles, Prof Doran also leads the graduate taught programme in clinical and translational research at UCD and Chairs the Biomedical research Degrees Committee at the UCD School of Medicine.

                  • Prof. John Forbes
                    Prof. John Forbes

                    John Forbes is the Professor of Health Economics at the University of Limerick and an HRB Research Leader with a particular interest in the economics of personalised health. Born and educated in California, he studied economics at the University of California at Berkeley. He received his MSc at the University of York and PhD at the University of Glasgow. Prior to joining the Graduate Entry Medical School at Limerick he worked at the Usher Institute of Population Health Sciences and Informatics in the College of Medicine and Veterinary Medicine at the University of Edinburgh. John’s research interests range from the estimation and interpretation of treatment effects to the microeconometric analysis of health data. He has a particular interest in how economic analysis can be used alongside randomized controlled trials and other fair tests of innovations in health care. He has extensive experience of designing and conducting trials of services for people following stroke and continues to collaborate with colleagues in stroke research networks across the world. Innovative and complex health service interventions have been evaluated in acute clinical areas including vascular medicine and surgery, musculoskeletal services, rheumatology, intensive care and clinical therapies. He has also conducted trials of novel health, therapeutic and behavioural programmes delivered in family, household and community settings. These include programmes directed at changing behavior and improving health for people at risk of diabetes and vascular complications and the impact of cognitive behavior therapy delivered via a eHealth platform for people with moderate depression. He has published more than 135 research articles in leading journals and his research sponsors include the Health Research Board (Dublin), the Medical Research Council, the National Institute for Health Research, the Health Technology Assessment Programme, the Scottish Executive, major medical charities and the European Union.

                    • Prof. Michael Gill

                      Professor Michael Gill (MD, MRCPsych FTCD) is Professor of Psychiatry and Head of School of Medicine at Trinity College Dublin. Between 2012 and 2017 he was Director and Principle Investigator of the Wellcome/HRB Clinical Research Facility at St. James’ Hospital that opened in 2013 and has successfully completed round two funding for 2018 to 2021. He is a Board member of Clinical Research Coordination Ireland and a previous Director of the HRB Clinical Research Coordination Ireland. He is the Director and grant holder of the Wellcome -HRB Irish Clinical Academic Training (ICAT) programme, an all Island consortium of six Universities that will appoint and train clinician scientists across all specialities. He was appointed as Head of the School of Medicine at Trinity College Dublin in September 2017.

                      Subscribe to our Newsletter

                      Start typing and press Enter to search

                      X